NCT01865929

Brief Summary

A randomised controlled trial comparing hysterectomy by minimally invasive surgical methods; robotic hysterectomy versus vaginal hysterectomy or traditional laparoscopic hysterectomy; outcome and cost analyses.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
124

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2010

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2010

Completed
3.3 years until next milestone

First Submitted

Initial submission to the registry

April 8, 2013

Completed
2 months until next milestone

First Posted

Study publicly available on registry

May 31, 2013

Completed
1 day until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2013

Completed
Last Updated

March 4, 2024

Status Verified

February 1, 2024

Enrollment Period

3.4 years

First QC Date

April 8, 2013

Last Update Submit

February 29, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Cost of surgery

    The cost of surgery includes the actual surgery (anaesthesia, OR-nurse, circulating nurse, doctors and use of the OR) as well as the length of the inpatient stay. The cost for conversions to open surgery, reoperations, readmissions, and any additional cost associated with additional procedures or medical interventions such as radiological examinations and blood transfusions. Based on the estimated cost of surgical material, use of the operating room and cost of anaesthesia each benign hysterectomy performed with robotic surgery would need to be 50 minutes shorter than other minimal invasive procedures to compensate for the additional cost.

    4 months

Secondary Outcomes (1)

  • Patient outcome

    4 months

Other Outcomes (1)

  • Social cost

    4 months

Study Arms (2)

Robotic hysterectomy

ACTIVE COMPARATOR

Minimally invasive hysterectomy by robotic surgery

Procedure: Vaginal or laparoscopic hysterectomy

Vaginal or laparoscopic hysterectomy

ACTIVE COMPARATOR

Minimal invasive hysterectomy by vaginal or traditional laparoscopic surgery.

Device: Robotic hysterectomy

Interventions

Minimally invasive hysterectomy for benign disorders. Comparing robotic hysterectomy with vaginal hysterectomy and traditional laparoscopic hysterectomy

Also known as: da Vinci Surgical system, Intuitive Surgical Inc, CA, USA
Vaginal or laparoscopic hysterectomy

Benign hysterectomy performed by traditional minimal invasive procedures.

Robotic hysterectomy

Eligibility Criteria

Age25 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • indication for hysterectomy for benign disease or prophylactic surgery due to hereditary cancer
  • size of uterus and vagina allows for retrieval by the vaginal route
  • maximum uterine size equivalent to 16 weeks of pregnancy
  • informed consent

You may not qualify if:

  • malignant disease
  • known extensive intra-abdominal adhesions
  • anaesthesiological contraindications to laparoscopic surgery
  • women with pacemaker or other implants where electrosurgery is to be avoided
  • immunoincompetent women
  • simultaneous need for prolapse surgery
  • women with known defects of the hemostasis
  • allergies towards metronidazole and doxycycline
  • inability to understand patient information

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Obstetrics and Gynecology, Skane University Hospital

Lund, 221 85, Sweden

Location

MeSH Terms

Conditions

MenorrhagiaMetrorrhagiaLeiomyomaUterine Cervical Dysplasia

Condition Hierarchy (Ancestors)

Uterine HemorrhageUterine DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital DiseasesHemorrhagePathologic ProcessesPathological Conditions, Signs and SymptomsMenstruation DisturbancesNeoplasms, Muscle TissueNeoplasms, Connective and Soft TissueNeoplasms by Histologic TypeNeoplasmsPrecancerous ConditionsUterine Cervical Diseases

Study Officials

  • Jan Persson, MD, PhD

    Department of Obstetrics and Gynecology, Skane University Hospital, Lund

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 8, 2013

First Posted

May 31, 2013

Study Start

January 1, 2010

Primary Completion

June 1, 2013

Study Completion

June 1, 2013

Last Updated

March 4, 2024

Record last verified: 2024-02

Locations